Antin JH - Search Results

1

Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.

Chen YB, Coughlin E, Kennedy KF, Alyea EP, Armand P, Attar EC, Ballen KK, Cutler C, Dey BR, Koreth J, McAfee SL, Spitzer TR, Antin JH, Soiffer RJ, Ho VT. Chen YB, et al. Among authors: antin jh. Biol Blood Marrow Transplant. 2013 Jun;19(6):981-7. doi: 10.1016/j.bbmt.2013.03.016. Epub 2013 Apr 2. Biol Blood Marrow Transplant. 2013. PMID: 23562738 Free article.

2

Herpes simplex virus and neutropenia following bone marrow transplantation.

Ballen KK, Donadio D, Bouloux C, McCarthy P, Weinstein H, Antin JH. Ballen KK, et al. Among authors: antin jh. Transplantation. 1992 Sep;54(3):553-5. Transplantation. 1992. PMID: 1412737 No abstract available.

3

Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease.

Antin JH, Weinstein HJ, Guinan EC, McCarthy P, Bierer BE, Gilliland DG, Parsons SK, Ballen KK, Rimm IJ, Falzarano G, et al. Antin JH, et al. Blood. 1994 Aug 15;84(4):1342-8. Blood. 1994. PMID: 8049450 Free article.

4

Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes.

Ballen KK, Antin JH. Ballen KK, et al. Among authors: antin jh. Hematol Oncol Clin North Am. 1993 Apr;7(2):477-93. Hematol Oncol Clin North Am. 1993. PMID: 8468276 Review.

5

Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.

Porter DL, Roth MS, Lee SJ, McGarigle C, Ferrara JL, Antin JH. Porter DL, et al. Among authors: antin jh. Bone Marrow Transplant. 1996 Nov;18(5):975-80. Bone Marrow Transplant. 1996. PMID: 8932854

6

High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.

Wheeler C, Eickhoff C, Elias A, Ibrahim J, Ayash L, McCauley M, Mauch P, Schwartz G, Eder JP, Mazanet R, Ferrara J, Rimm IJ, Guinan E, Bierer B, Gilliland G, Churchill WH, Ault K, Parsons S, Antman K, Schnipper L, Tepler I, Gaynes L, Frei E 3rd, Kadin M, Antin J. Wheeler C, et al. Biol Blood Marrow Transplant. 1997 Jun;3(2):98-106. Biol Blood Marrow Transplant. 1997. PMID: 9267670 Clinical Trial.

7

Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia.

Ballen KK, Gilliland DG, Guinan EC, Hsieh CC, Parsons SK, Rimm IJ, Ferrara JL, Bierer BE, Weinstein HJ, Antin JH. Ballen KK, et al. Among authors: antin jh. Bone Marrow Transplant. 1997 Nov;20(9):737-43. doi: 10.1038/sj.bmt.1700971. Bone Marrow Transplant. 1997. PMID: 9384475 Clinical Trial.

8

Guillain-Barré syndrome following allogeneic bone marrow transplantation.

Wen PY, Alyea EP, Simon D, Herbst RS, Soiffer RJ, Antin JH. Wen PY, et al. Among authors: antin jh. Neurology. 1997 Dec;49(6):1711-4. doi: 10.1212/wnl.49.6.1711. Neurology. 1997. PMID: 9409375 Review.

9

Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation.

Sehn LH, Antin JH, Shulman LN, Mauch P, Elias A, Kadin ME, Wheeler C. Sehn LH, et al. Among authors: antin jh. Blood. 1998 Jan 15;91(2):717-23. Blood. 1998. PMID: 9427731 Free article.

10

A comparison of related and unrelated marrow donors.

Chang G, McGarigle C, Spitzer TR, McAfee SL, Harris F, Piercy K, Goetz MN, Antin JH. Chang G, et al. Among authors: antin jh. Psychosom Med. 1998 Mar-Apr;60(2):163-7. doi: 10.1097/00006842-199803000-00009. Psychosom Med. 1998. PMID: 9560864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

503 results

Search Page

Filters